| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/05/2011 | US20110105562 Alkynyl derivatives useful as dpp-1 inhibitors |
| 05/05/2011 | US20110105549 Branched 3- and 6-substituted quinolines as cgrp receptors antagonists |
| 05/05/2011 | US20110105543 Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors |
| 05/05/2011 | US20110105539 2'-halobiphenyl-4-yl intermediates in the synthesis of angiotensin ii antagonists |
| 05/05/2011 | US20110105537 5,7-disubstituted thiazolo[4,5-d]pyrimidines for the selective inhibition of chemokine receptors |
| 05/05/2011 | US20110105535 Inhibitors of phosphatidylinositol 3-kinase |
| 05/05/2011 | US20110105533 Heterocyclic Sulfonamides, Uses and Pharmaceutical Compositions Thereof |
| 05/05/2011 | US20110105523 Bifeprunox derivatives |
| 05/05/2011 | US20110105508 Quinoxaline and quinoline derivatives as kinase inhibitors |
| 05/05/2011 | US20110105505 Thiazolyl piperidine derivatives |
| 05/05/2011 | US20110105499 Pyrazolo-Pyrazinone Compounds and Methods of Use Thereof |
| 05/05/2011 | US20110105498 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereof |
| 05/05/2011 | US20110105496 Methods For The Treatment Of Myosin Heavy Chain-Mediated Conditions Using 4,7-Dihydrothieno[2,3-B]Pyridine Compounds |
| 05/05/2011 | US20110105490 2,3-dihydro-1h-isoindol-1-imine derivatives useful as thrombin par-1 receptor antagonist |
| 05/05/2011 | US20110105464 Phosphoinositide 3-kinase inhibitor compounds and methods of use |
| 05/05/2011 | US20110105459 Azetidines and cyclobutanes as histamine h3 receptor antagonists |
| 05/05/2011 | US20110105458 Fatty acid inhibitors |
| 05/05/2011 | US20110105456 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 05/05/2011 | US20110105455 Phenoxy-substituted pyrimidines as opioid receptor modulators |
| 05/05/2011 | US20110105452 Oxidant Scavengers for Treatment of Diabetes or Use in Transplantation or Induction of Immune Tolerance |
| 05/05/2011 | US20110105447 Novel modulators of calcium release-activated calcium channel |
| 05/05/2011 | US20110105427 Deazapurines and uses thereof |
| 05/05/2011 | US20110105424 Glucopyranoside compound |
| 05/05/2011 | US20110105400 Methods for treating acute myocardial infarction |
| 05/05/2011 | US20110105399 Prevention and treatment of inflammation and organ injury after ischemia/reperfusion using mfg-e8 |
| 05/05/2011 | US20110105397 Method for treating heart failure with stresscopin-like peptides |
| 05/05/2011 | US20110105396 Tgf-beta3 mutants |
| 05/05/2011 | US20110105395 Methods for treating a neurological disorder by peripheral administration of a trophic factor |
| 05/05/2011 | US20110105394 Amylin Derivatives |
| 05/05/2011 | US20110105389 Macrocyclic Ghrelin Receptor Antagonists and Inverse Agonists and Methods of Using the Same |
| 05/05/2011 | US20110105382 Calmodulin-binding peptides that reduce cell proliferation in cancer and smooth muscle proliferation diseases |
| 05/05/2011 | US20110104308 Treatment For Diseases Relying On Discovery That Thioredoxin Mediates Nitric Oxide |
| 05/05/2011 | US20110104297 Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders |
| 05/05/2011 | US20110104286 Pharmaceutical compositions containing the enzyme cyprosin, an aspartic peptidase from cynara cardunculus and its inclusion in antitumour formulations |
| 05/05/2011 | US20110104277 Oxygen barrier film coatings for pharmaceutical dosage forms |
| 05/05/2011 | US20110104276 Pharmaceutical composition containing as an active ingredient 5-methyl-1-phenyl-2-(1h)-pyridone |
| 05/05/2011 | US20110104273 Gastric retentive pharmaceutical compositions for immediate and extended release of phenylephrine |
| 05/05/2011 | US20110104247 Composition for stabilizing beta-blocker and transdermally absorbable preparation comprising the same |
| 05/05/2011 | US20110104234 Biodegradable Modified Carpolactone Polymers for Fabrication and Coating Medical Devices |
| 05/05/2011 | US20110104228 Self-eliminating coatings |
| 05/05/2011 | US20110104217 Bioactive Peptides and Method of Using Same |
| 05/05/2011 | US20110104215 Transdermally absorbable preparation |
| 05/05/2011 | US20110104213 Porous Biomolecule-Containing Metal-Organic Frameworks |
| 05/05/2011 | US20110104206 Methods and compositions for sustained delivery of drugs |
| 05/05/2011 | US20110104185 Antibody fragment-polymer conjugates and uses of same |
| 05/05/2011 | US20110104176 Antibody specifically binding to c-met and use thereof |
| 05/05/2011 | US20110104172 Inhibitors of gm-csf and il-17 for therapy |
| 05/05/2011 | US20110104169 Regulator genes of angiogenesis, pharmaceutical preparations containing them and their applications |
| 05/05/2011 | US20110104155 Drug delivery to the anterior and posterior segments of the eye using eye drops |
| 05/05/2011 | US20110104152 Chimeric fibroblast growth factors with altered receptor specificity |
| 05/05/2011 | US20110104146 Antithrombotic agents and methods of use thereof |
| 05/05/2011 | US20110104132 Fgf-9 and its use relating to blood vessels |
| 05/05/2011 | US20110104131 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| 05/05/2011 | US20110104127 mRNA-TRANSFECTION OF ADULT PROGENITOR CELLS FOR SPECIFIC TISSUE REGENERATION |
| 05/05/2011 | US20110104124 Mesodermal-like cell population for treating ischemia in mammals |
| 05/05/2011 | US20110104123 Therapeutic protocol using stem cells in tissue and neuronal repair, maintenance, regeneration and augmentation |
| 05/05/2011 | US20110104122 Efficient production and use of highly cardiogenic progenitors and cardiomyocytes from embryonic and induced pluripotent stem cells |
| 05/05/2011 | US20110104120 Directed Evolution and In Vivo Panning of Virus Vectors |
| 05/05/2011 | US20110104119 Chimeric Vectors |
| 05/05/2011 | US20110104116 Hsa-free formulations of interferon-beta |
| 05/05/2011 | US20110104107 Compositions and methods for reducing the likelihood of preeclampsia in recipients of artificial insemination |
| 05/05/2011 | US20110104103 Method of conjugating therapeutic compounds to cell targeting devices via metal complexes |
| 05/05/2011 | US20110104066 Prophylactic/therapeutic agents for lifestyle-related diseases |
| 05/05/2011 | US20110104061 Treatment of renal hypertension or carotid sinus syndrome with adventitial pharmaceutical sympathetic denervation or neuromodulation |
| 05/05/2011 | US20110104059 Membrane Associated Tumor Endothelium Markers |
| 05/05/2011 | DE102009044375A1 Use of a compound, preferably an inhibitor of aldosterone synthase comprising e.g. 4-androstene-4-ol-3,17-dione or 4-androstene-3,17-dione, for the treatment and/or prevention of hyperaldosteronism and/or cardiovascular disease |
| 05/05/2011 | CA2779162A1 Concentrated therapeutic phospholipid compositions |
| 05/05/2011 | CA2779161A1 Yellow pea seed protein-derived peptides |
| 05/05/2011 | CA2779118A1 Hypoxia regulated conditionally silenced aav expressing angiogenic inducers |
| 05/05/2011 | CA2778990A1 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same |
| 05/05/2011 | CA2778890A1 Glycosylated form of antigenic glp-1 analogue |
| 05/05/2011 | CA2778884A1 Preparation comprising amino acids and plants and its activity in the alcohol detoxification |
| 05/05/2011 | CA2778756A1 Benzazepine compound |
| 05/05/2011 | CA2777152A1 Substituted 3-phenylpropionic acids and the use thereof |
| 05/04/2011 | EP2316968A1 Antisense modulation of apolipoprotein (A) expression |
| 05/04/2011 | EP2316944A2 Binding agents: chimeric ligand/receptor proteins |
| 05/04/2011 | EP2316939A2 Novel peptide |
| 05/04/2011 | EP2316922A1 Neutralizing human anti-IGFR antibody |
| 05/04/2011 | EP2316921A1 Neutralizing human anti-IGFR antibody |
| 05/04/2011 | EP2316919A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 05/04/2011 | EP2316918A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 05/04/2011 | EP2316845A1 Specific binding agents of human angiopoietin-2 |
| 05/04/2011 | EP2316488A1 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 05/04/2011 | EP2316455A1 Pharmaceutical compositions for treating cancer |
| 05/04/2011 | EP2316450A1 Amino-methyl substituted tetracycline compounds |
| 05/04/2011 | EP2316447A1 Method of inhibiting remnant lipoprotein production |
| 05/04/2011 | EP2316445A1 HUMAN beta3 ADRENERGIC RECEPTOR LIGAND, AND FOOD OR PHARMACEUTICAL PRODUCT CONTAINING THE SAME |
| 05/04/2011 | EP2316377A1 Drug-Delivery Endovascular Stent And Method For Treating Restenosis |
| 05/04/2011 | EP2315829A2 Induced pluripotent stem cells |
| 05/04/2011 | EP2315768A1 Thieno-pyridine derivatives as mek inhibitors |
| 05/04/2011 | EP2315765A2 Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use |
| 05/04/2011 | EP2315600A2 Compositions and methods related to sirt1 function |
| 05/04/2011 | EP2315592A1 Treatment of pulmonary arterial hypertension |
| 05/04/2011 | EP2315587A2 Therapeutic compositions containing macitentan |
| 05/04/2011 | EP2213669A9 Crystalline imidazol-5-carboxylic acid derivate |
| 05/04/2011 | EP2128248B1 Oligonucleotide compositions with enhanced efficiency |
| 05/04/2011 | EP2011497B1 Phenotropil for the prophylaxis and treatment of hemorrhagic stroke and acute phase of ischemic stroke |
| 05/04/2011 | EP1855661B1 Formulation for aviptadil |
| 05/04/2011 | EP1551412B1 Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 05/04/2011 | EP1446100B1 Injectable depot compositions and uses thereof |